Human Longevity Lands $220,000,000 Series B Round

  • Feed Type
  • Date
    4/5/2016
  • Company Name
    Human Longevity
  • Mailing Address
    10835 Road to the Cure San Diego, CA 92121 USA
  • Company Description
    HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy.
  • Website
    http://www.humanlongevity.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $220,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    HLI is using the proceeds from this round to fund the growth and expansion of the company and our growing line of products. These include the first Health Nucleus, HLI’s comprehensive, genomic-enhanced, research-based health center; ongoing development of the HLI Knowledgebase which currently has more than 20,000 complete genomes coupled with phenotype data; the Comprehensive Cancer Program and other sequencing programs.
  • M&A Terms
  • Venture Investor
    Illumina
  • Venture Investor
    Celgene
  • Venture Investor
    GE Ventures
  • Venture Investor
    Undisclosed

Trending on Xconomy